November 18, 2026
Health news, explained with evidence
LIVE
CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee

Genetic 'Dimmer Switch' May Explain Variable Severity in Rare Muscular Dystrophy

❤️ Conditions & Care 2 min read 👁 12

Researchers from University of Utah Health have discovered that DNA methylation acts as a biological dimmer switch, helping explain why patients with the same genetic mutation for facioscapulohumeral muscular dystrophy experience vastly different symptom severities.

Genetic 'Dimmer Switch' May Explain Variable Severity in Rare Muscular Dystrophy❤️Conditions & Care

Photo: Medical Xpress

Key points

  • University of Utah Health researchers studied a nine-generational family to understand FSHD symptom variability.
  • DNA methylation at the DUX4 gene acts like a dimmer switch, where higher levels correlate with milder symptoms.
  • A secondary gene, HDGFL3, was identified as potentially playing a role in regulating these methylation levels.

A new study led by investigators at University of Utah Health sheds light on a long-standing medical mystery regarding facioscapulohumeral muscular dystrophy (FSHD), a rare genetic condition that progressively weakens facial, shoulder, and limb muscles. Although individuals carrying the specific genetic alteration linked to FSHD will develop the condition, the severity of symptoms varies dramatically. For instance, two siblings in the study who inherited the identical genetic change had vastly different trajectories: the brother experienced severe mobility loss by middle age, while the sister remained only mildly affected into her late thirties.

By analyzing historical clinical records and multi-generational DNA samples dating back to the 1980s from a unique nine-generation family, the research team investigated DNA methylation at the DUX4 gene. Methylation functions similarly to a dimmer switch, reducing gene activity or muting it entirely. Using a specialized long-read sequencing method designed to navigate the complex, repetitive genetic region of DUX4, the scientists found that higher methylation levels are linked to milder disease outcomes.

Potential New Target for Future Therapies

Furthermore, the investigation pointed to a potential secondary genetic contributor. Participants with elevated DUX4 methylation often shared a specific DNA variation near a little-studied gene called HDGFL3. While the exact role of HDGFL3 remains to be fully defined, its structural profile suggests it may interact with DNA to regulate methylation patterns, offering a fresh avenue for future therapeutic research.

  • What was studied: The link between DUX4 DNA methylation and symptom severity in FSHD using multi-generational family DNA samples and advanced sequencing.
  • Key finding: Higher levels of methylation at the DUX4 gene are associated with milder disease symptoms, potentially regulated in part by the HDGFL3 gene.
  • Study limits: The research relies heavily on historical data and a specific multi-generational family cohort, and the findings remain observational at this stage.
Always consult a qualified healthcare professional for guidance regarding personal medical decisions, genetic testing, or chronic condition management.

Source Medical Xpress — medicalxpress.com/news/2026-11-genetic-dimmer-severe-disease-rare.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.